Morningstar Investor users sign in here.

Company Profile

  • Business description

    Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

  • Contact

    Route 206 and Province Line Road
    Princeton
    New Jersey NJ 08543
    USA

    T: +1 609 252-4621

    E: timothy.power@bms.com

    https://www.bms.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    34,100

Bristol-Myers Squibb Co News & Analysis

stocks

The 10 best US dividend shares

These undervalued stocks with reliable dividends are worth considering.
stocks

10 best US blue-chip shares to buy for the long term

The stocks of these high-quality companies with large market capitalizations look undervalued today.
stocks

The 10 best US dividend shares

These undervalued stocks with reliable dividends are worth considering.

Market Movers

Name
Last price
Change
% Change
Jupiter Mines Ltd JMS 0.32 0.04 -9.86%
Sayona Mining Ltd SYA 0.04 0.01 -12.24%
Telstra Group Ltd TLS 3.57 0.10 -2.72%
The Star Entertainment Group Ltd SGR 0.50 0.04 -7.41%
South32 Ltd S32 3.90 0.01 0.26%
Imugene Ltd IMU 0.07 0.00 0.00%
Alligator Energy Ltd AGE 0.07 0.00 3.08%
Pilbara Minerals Ltd PLS 4.15 0.05 -1.19%
Red 5 Ltd RED 0.49 0.02 3.16%
Peninsula Energy Ltd PEN 0.12 0.01 -4.17%